
Adagene ADAG
€ 1.50
0.77%
Geschäftsbericht 2024
hinzugefügt 13.12.2025
Adagene Betriebszyklus 2011-2025 | ADAG
Betriebszyklus Jährlich Adagene
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 53.8 | 125 | 182 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 182 | 53.8 | 120 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.9 | 4.03 % | $ 813 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.21 | -1.38 % | $ 248 M | ||
|
Aptevo Therapeutics
APVO
|
191 | $ 1.06 | -6.22 % | $ 293 K | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 13.33 | -5.39 % | $ 878 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Celldex Therapeutics
CLDX
|
86.5 | $ 27.09 | -1.53 % | $ 1.74 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
364 | $ 88.51 | 0.59 % | $ 9.14 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
137 | $ 24.35 | 3.07 % | $ 2.88 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Dynavax Technologies Corporation
DVAX
|
512 | $ 10.88 | 0.74 % | $ 1.41 B | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
195 | $ 26.44 | 4.63 % | $ 1.28 B | ||
|
Anika Therapeutics
ANIK
|
325 | $ 9.6 | 0.42 % | $ 141 M | ||
|
Eton Pharmaceuticals
ETON
|
55.7 | $ 15.97 | -4.37 % | $ 410 M | ||
|
Evogene Ltd.
EVGN
|
30 | $ 1.04 | -3.7 % | $ 27.9 M | ||
|
Exelixis
EXEL
|
172 | $ 41.27 | 0.95 % | $ 12 B | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
116 | $ 551.37 | -2.29 % | $ 41.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
360 | $ 2.35 | 2.17 % | $ 14.8 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 91.19 | 1.51 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
408 | $ 11.25 | -2.43 % | $ 728 M | ||
|
Biogen
BIIB
|
452 | $ 174.69 | 0.34 % | $ 25.4 B |